Company intelligence / Profile preview
Defence Therapeutics
Vancouver, British Columbia, Canadaadmarebio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Defence Therapeutics has developed the proprietary Accum™ technology for precision drug delivery, significantly enhancing the efficacy of ADCs and radiopharmaceuticals. The company’s pipeline includes immune-oncology vaccines and next-generation ADC products targeting cancer and infectious diseases. Recent collaborations include preclinical studies with Canadian Nuclear Laboratories on Actinium-based radiotherapies. The company has announced plans to license its technology to other pharma/biotech companies developing ADCs[1][3][4].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Antibody Drug Conjugates (ADCs)Radiopharmaceuticals / Radio-immuno-conjugatesImmune-oncology vaccines (including mRNA and cell-based vaccines)
- Industry
- Biotech
02
Drug pipeline
22 assets21 more assets in the full pipeline.
Request access →03
Partnerships
Canadian Nuclear Laboratories – collaboration on Actinium-based radiotherapy using Accum® technology[4].
Beyond the preview
Go deeper on Defence Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Defence Therapeutics.